Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87.4M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
17.2M
-
Shares change
-
-1.26M
-
Total reported value, excl. options
-
$27.2M
-
Value change
-
-$2.9M
-
Number of buys
-
18
-
Number of sells
-
-16
-
Price
-
$1.58
Significant Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q1 2024
50 filings reported holding TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.2M shares
of 87.4M outstanding shares and own 19.69% of the company stock.
Largest 10 shareholders include FMR LLC (4.75M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.36M shares), VANGUARD GROUP INC (1.78M shares), Balyasny Asset Management L.P. (1.73M shares), Kent Lake Capital LLC (1.19M shares), Triatomic Management LP (885K shares), CINCINNATI INSURANCE CO (700K shares), TIFF ADVISORY SERVICES, LLC (423K shares), GEODE CAPITAL MANAGEMENT, LLC (354K shares), and FourWorld Capital Management LLC (250K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.